Michael Rosenblatt - 19 May 2022 Form 3 Insider Report for Axcella Health Inc. (AXLA)

Role
Director
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
AXLA
Transactions as of
19 May 2022
Transactions value $
$0
Form type
3
Filing time
23 May 2022, 16:53:07 UTC
Previous filing
13 May 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AXLA Common Stock 3.05K 19 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXLA Stock Option (Right to Buy) 19 May 2022 Common Stock 3.73K $6.52 Direct F1
holding AXLA Stock Option (Right to Buy) 19 May 2022 Common Stock 4.07K $6.21 Direct F1
holding AXLA Stock Option (Right to Buy) 19 May 2022 Common Stock 5.43K $13.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable as of the date hereof.
F2 4,408 shares underlying this option are fully vested and exercisable, with the remainder vesting in substantially equal installments on each of June 30, 2022, September 30, 2022 and December 31, 2022.

Remarks:

Exhibit 24 - Power of Attorney